Literature DB >> 34989899

Development of an optimization pipeline of asymmetric PCR towards the generation of DNA aptamers: a guide for beginners.

Tzi Shien Yeoh1, Andrew Anna1,2, Thean-Hock Tang1, Marimuthu Citartan3.   

Abstract

Asymmetric PCR is one of the most utilized strategies in ssDNA generation towards DNA aptamer generation due to its low cost, robustness and the low amount of starting template. Despite its advantages, careful optimization of the asymmetric PCR is still warranted to optimize the yield of ssDNA. In this present study, we have developed an extensive optimization pipeline that involves the optimization of symmetric PCR initially followed by the optimization of asymmetric PCR. In the asymmetric PCR, optimization of primer amounts/ratios, PCR cycles, annealing temperatures, template concentrations, Mg2+/dNTP concentrations and the amounts of Taq Polymerase was carried out. To further boost the generation of ssDNA, we have also integrated an additional single-stranded DNA generation method, either via lambda exonuclease or biotin-streptavidin-based separation into the optimization pipeline to further improve the yield of ssDNA generation. We have acquired 700 ± 11.3 and 820 ± 19.2 nM for A-PCR-lambda exonuclease and A-PCR-biotin-streptavidin-based separation, respectively. We urge to develop a separate optimization pipeline of asymmetric PCR for each different randomized ssDNA library before embarking on any SELEX studies.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Asymmetric PCR; Biotin-streptavidin-based separation; Lambda exonuclease digestion; ssDNA

Mesh:

Substances:

Year:  2022        PMID: 34989899     DOI: 10.1007/s11274-021-03209-w

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  1 in total

1.  Challenges to design and develop of DNA aptamers for protein targets. I. Optimization of asymmetric PCR for generation of a single stranded DNA library.

Authors:  Maryam Tabarzad; Bahram Kazemi; Hossein Vahidi; Reza Aboofazeli; Soraya Shahhosseini; Nastaran Nafissi-Varcheh
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.